Literature DB >> 32861577

Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging.

Fabian Bartsch1, Felix Hahn2, Lukas Müller2, Janine Baumgart1, Maria Hoppe-Lotichius1, Roman Kloeckner2, Hauke Lang3.   

Abstract

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) still has a poor long-term outcome, even after complete resection. We investigated different parameters gathered in preoperative imaging and analyzed their influence on resectability, recurrence, and survival.
METHODS: All patients who underwent exploration due to ICC between January 2008 and June 2018 were analyzed retrospectively. Kaplan-Meier model, log-rank test and Cox regression were used.
RESULTS: Out of 184 patients, 135 (73.4%) underwent curative intended resection. Median overall survival (OS) was 22.2 months with a consecutive 1-, 3- and 5-year OS of 73%, 29%, and 17%. Median recurrence-free survival (RFS) was 9.3 months with a consecutive 1-, 3- and 5-year RFS of 36%, 15%, and 11%. Site of tumor, parenchymal localization, tumor configuration/dissemination, and estimated tumor volume had significant influence on resectability. Univariate analyses showed that site of tumor, tumor configuration/dissemination, number of nodules, and estimated tumor volume had predictive values for OS and RFS. Together with tumor size the preoperative prediction (POP) score was created showing significance for OS and RFS (all P < 0.001). In multivariate analysis, POP score (HR = 1.779; 95% CI: 1.268-2.495; P = 0.001), T stage (HR = 1.255; 95% CI: 1.040-1.514; P = 0.018) and N stage (HR = 1.334; 95% CI: 1.081-1.645; P = 0.007) were the independent predictors for OS. For RFS, POP score (HR = 1.733; 95% CI: 1.300-2.311; P < 0.001) and M stage (HR = 3.036; 95% CI: 1.376-6.697; P = 0.006) were the independent predictors.
CONCLUSIONS: The POP score showed to have a highly significant influence on OS and RFS. The score is easy to assess through preoperative imaging. For patients in the high risk group at least staging laparoscopy or preoperative chemotherapy should be evaluated, because they showed equal outcome compared to the irresectable group.
Copyright © 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Liver surgery; Preoperative imaging; Survival

Mesh:

Year:  2020        PMID: 32861577     DOI: 10.1016/j.hbpd.2020.08.002

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  5 in total

1.  Hyper accuracy three-dimensional (HA3D™) technology for planning complex liver resections: a preliminary single center experience.

Authors:  Andrea Ruzzenente; Laura Alaimo; Simone Conci; Mario De Bellis; Andrea Marchese; Andrea Ciangherotti; Tommaso Campagnaro; Alfredo Guglielmi
Journal:  Updates Surg       Date:  2022-08-25

2.  Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma.

Authors:  Linping Cao; Jiawei Hong; Jian Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 3.  [Evidence of minimally invasive oncological surgery of the liver].

Authors:  Stefan Heinrich; Hauke Lang
Journal:  Chirurg       Date:  2021-01-15       Impact factor: 0.955

Review 4.  Integrative Concepts for Liver Surgery.

Authors:  Stefan Heinrich; Felix Watzka; Hauke Lang
Journal:  Visc Med       Date:  2020-09-17

Review 5.  Robotic-Assisted Surgery for Primary Hepatobiliary Tumors-Possibilities and Limitations.

Authors:  Julia Spiegelberg; Tanja Iken; Markus K Diener; Stefan Fichtner-Feigl
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.